Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000571

Drug Information
NameLisdexamfetamine
SynonymsD08130; Lisdexamfetamine (INN); MolPort-004-285-960; CID11597698; UNII-H645GUL8KJ; DB01255; LS-187377; Lisdexamfetamine; 608137-32-2; NRP104
Trade NameVyvanse
CompanyNew River Pharmaceuticals
IndicationAttention deficit hyperactivity disorder
[ICD9: 314.0   ICD10: F90]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/
h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1
InChIKeyVOBHXZCDAVEXEY-JSGCOSHPSA-N
Canonical SMILESCC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N    
Isomeric SMILESC[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N
Therapeutic ClassCentral Nervous System Agents
CAS NumberCAS 608137-32-2
FormulaC15H25N3O
PubChem Compound IDCID 11597698.
PubChem Substance IDSID 16843305.
SuperDrug ATC IDN06BA12
N06BA12
TargetAlpha-1B adrenergic receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021977 To Reference
Ref 2Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543